Welcome to LookChem.com Sign In|Join Free

CAS

  • or

82816-38-4

Post Buying Request

82816-38-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

82816-38-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 82816-38-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,8,1 and 6 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 82816-38:
(7*8)+(6*2)+(5*8)+(4*1)+(3*6)+(2*3)+(1*8)=144
144 % 10 = 4
So 82816-38-4 is a valid CAS Registry Number.

82816-38-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name [diphenyl(prop-2-ynoxy)methyl]benzene

1.2 Other means of identification

Product number -
Other names trityl propargyl ether

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:82816-38-4 SDS

82816-38-4Relevant articles and documents

Hypervalent Iodine Based Reversible Covalent Bond in Rotaxane Synthesis

Kandrnálová, Markéta,Kokan, Zoran,Havel, Václav,Ne?as, Marek,?indelá?, Vladimír

supporting information, p. 18182 - 18185 (2019/11/14)

Reversible covalent bonds play a significant role in achieving the high-yielding synthesis of mechanically interlocked molecules. Still, only a handful of such bonds have been successfully employed in synthetic procedures. Herein, we introduce a novel app

2-ACYLAMINOTHIAZOLES FOR THE TREATMENT OF CANCER

-

Page/Page column 85, (2015/01/16)

The present invention relates to inhibitors of the oncogenic protein kinase ALK of formula (I) as herein described and pharmaceutical compositions thereof. The compounds of formula (I) are useful in the preparation of a medicament, in particular for the treatment of cancer.

A convergent approach toward the C1-C11 subunit of phoslactomycins and formal synthesis of phoslactomycin b

Ais, Valerie Dru,Hall, Michael J.,Corsi, Camilla,Wendeborn, Sebastian V.,Meyer, Christophe,Cossy, Janine

supporting information; experimental part, p. 935 - 938 (2009/08/07)

The preparation of the C1-C11 subunit of phoslactomycins, and a formal synthesis of phoslactomycin B, were achieved by a convergent strategy involving the chelation-controlled addition of an alkynyl Grignard reagent to an α-alkoxy ketone. Catalytic enanti

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 82816-38-4